Altair Announces Fourth Quarter and Full Year 2017 Financial Results
Mar 21, 2018 20:05 pm UTC| Business
TROY, Mich., March 21, 2018 -- Altair Engineering Inc. (NASDAQ:ALTR) today announced its financial results for the fourth quarter and full year ended December 31, 2017. “Altair delivered strong fourth quarter and full...
Sphere 3D Reports Fourth Quarter and Fiscal Year 2017 Financial Results
Mar 21, 2018 20:05 pm UTC| Business
SAN JOSE, Calif., March 21, 2018 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today reported financial results for its fourth quarter and fiscal year ended...
Mar 21, 2018 20:05 pm UTC| Business
CHARLESTON, S.C., March 21, 2018 -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) will announce its fourth quarter and year ended December 31, 2017 financial and operating results after market close on Tuesday, March...
Mar 21, 2018 20:05 pm UTC| Business
MONACO, March 21, 2018 -- Navios Maritime Midstream Partners L.P. ("Navios Midstream") (NYSE:NAP), announced that its Annual Report on Form 20-F for the year ended December 31, 2017 has been filed with the SEC and can...
Almaden Updates Feasibility Study at Ixtaca
Mar 21, 2018 20:05 pm UTC| Business
VANCOUVER, British Columbia, March 21, 2018 -- Almaden Minerals Ltd. (“Almaden” or “the Company”) (NYSE American:AAU) (TSX:AMM) is pleased to update investors on the environmental and engineering work relating to the...
Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL
Mar 21, 2018 20:05 pm UTC| Business
U.S. Patent Issued Covering the Use of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for treating Posttraumatic Stress Disorder (PTSD) Patent Will Provide Intellectual Property Protection until at least 2030 for Use...
TRACON Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
Mar 21, 2018 20:05 pm UTC| Business
SAN DIEGO, March 21, 2018 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet...